Marval Biosciences

BiotechnologySeries CHouston, USmarvalbiosciences.com

Latest round

Series C

Last raised

Jul 2012

Total raised

$5.6M

Investors

2

About Marval Biosciences

Founded in 2007 and based in Houston, Texas, Marval Biosciences operates as a life sciences company that develops biomedical imaging agents. It develops liposomal nanocarriers to deliver CT contrast agents that are used to diagnose acute chest pain and reduce toxicity to patients.

Who invested in Marval Biosciences

2 investors across 3 rounds

See all investors in Marval Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jul 25, 2012

    Amount

    $2.5M

    Investors

    Locked

  2. Series B

    Jan 19, 2010

    Amount

    $2.5M

    Investors

    Locked

  3. Series A

    Sep 7, 2007

    Amount

    $0.6M

    Investors

    Locked

Questions about Marval Biosciences

Who invested in Marval Biosciences?

Marval Biosciences has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Marval Biosciences raised?

Marval Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Marval Biosciences last raise money?

Marval Biosciences's most recent round on record is a Series C, in Jul 2012.

What does Marval Biosciences do?

Founded in 2007 and based in Houston, Texas, Marval Biosciences operates as a life sciences company that develops biomedical imaging agents.

Where is Marval Biosciences headquartered?

Marval Biosciences is headquartered in Houston, US.

Which VCs invest in companies like Marval Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Marval Biosciences's stage. Their profiles are linked below.

Raising like Marval Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.